Potent antitumor activity of the combination of HSV-TK and endostatin by adeno-associated virus vector for bladder cancer in vivo

Clinical Laboratory

Volumn 59, Issue 9-10, 2013, Pages 1147-1158

  Pan, Jian Gang ^a   Luo, Run Qi ^a   Zhou, Xing ^a   Han, Rui Fa ^b   Zeng, Ge Wa ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Adeno associated virus; Bladder cancer; Endostatin; Gene therapy; HSV

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOSTATIN; HERPES SIMPLEX VIRUS THYMIDINE KINASE; UNCLASSIFIED DRUG;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CANCER; CONTROLLED STUDY; GENE THERAPY; IN VIVO STUDY; INVERTED TERMINAL REPEAT; MONOTHERAPY; MOUSE; NONHUMAN; TUMOR GROWTH;

ANIMALS; CELL LINE; DEPENDOVIRUS; ENDOSTATINS; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, NUDE; SIMPLEXVIRUS; THYMIDINE KINASE; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84886403264     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.121109     Document Type: Article

References (30)

1. Voutsinas GE, Stravopodis DJ. Molecular targeting and gene delivery in bladder cancer therapy. J BUON 2009 Sep; 14 Suppl 1: S69-78.
2. Arakawa M, Nakamura K, Yamada Y, et al. Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect. Exp Ther Med 2011;2(5):901-5.
3. Malkowicz SB. Intravesical therapy for superficial bladder cancer. Semin Urol Oncol 2000;18:280-8.
4. Edelman MJ. New approaches to treatment of metastatic bladder cancer. Curr Oncol Rep 2000;2:379-85.
5. Block T. Chemotherapy of bladder carcinoma. Current status and trends. Urologe A 1994;33:557-67. (Pubitemid 24360556)
6. Witjes JA, Wullink M, Oosterhof GO, de Mulder P. Toxicity and results of MVAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced urothelial carcinoma. Eur Urol. 1997;31:414-9. (Pubitemid 27234629)
7. Freund CTF, Tong XW, Rowley D, et al. Combination of adenovirus-mediated thymidine kinase gene therapy with cytotoxic chemotherapy in bladder cancer in vitro. Urologic Oncology: Seminars and Original Investigations 2003;21:197-205. (Pubitemid 36723707)
8. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
9. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiotherapy and Oncology 2003;66:1-9. (Pubitemid 36135998)
10. Yu YF, Chen ZW, Li ZM, Li ZH, Lu S. The Effects of Cetuximab Alone and in Combination with Endostatin on Vascular Endothelial Growth Factor and Interleukin-8 Expression in Human Lung Adenocarcinoma Cells. Current Therapy Res 2009;70:116-28.
11. Li J, Li HM, Zhu L, et al. The adenovirus-mediated linamarase/linamarin suicide system: A potential strategy for the treatment of hepatocellular carcinoma. Cancer Letter 2010;289:217-27.
12. Fillat C, Carrio M, Cascante A, Sangro B. Suicide gene therapy mediated by the Herpes Simplex virus thymidine kinase gene/Ganciclovir system: fifteen years of application. Curr Gene Ther 2003;3:13-26.
13. Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001;61:3330-8. (Pubitemid 32695022)
14. Qiao J, Black ME, Caruso M. Enhanced ganciclovir killing and bystander effect of human tumor cells transduced with a retroviral vector carrying a herpes simplex virus thymidine kinase gene mutant. Hum Gene Ther 2000;11:1569-76. (Pubitemid 30670608)
15. Zhang Y, Ma H, Zhang J, Liu S, Liu Y, Zheng D. AAV-mediated TRAIL gene expression driven by hTERT promoter suppressed human hepatocellular carcinoma growth in mice. Life Sciences 2008;82:1154-61.
16. Pan JG, Zhou X, Zeng GW, Han RF. Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression. Tumor Biology 2011;32(2):301-10.
17. Pan JG, Zhou X, Luo RQ, Han RF. The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma. Med Oncol 2012;29(3):1938-47.
18. AAV Helper-Free System Instruction Manual. Revision A.02. www.stratagene.com.
19. Wu XB, Dong XY, Wu ZJ, et al. A novel method for purification of recombinant adenoassociated virus vectors on a large scale. Chinese Science Bulletin 2001;6:485-90.
20. Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector tool kit for human gene therapy. Mol Ther 2006;14:316-27. (Pubitemid 44184972)
21. XiaoX, Li J, Samulski RJ. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associate virus vector. J Virol 2009;70:8098-108.
22. Shi W, Teschendorf C, Muzyczka N, Siemann DW. Gene therapy delivery of endostatin enhances the treatment efficacy of radiation. Radiotherapy and Oncology 2003;66:1-9. (Pubitemid 36135998)
23. Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999;17:343-8. (Pubitemid 29166035)
24. Chen QR, Kumar D, Stass SA, Mixson AJ. Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice. Cancer Res 1999;59:3308-12. (Pubitemid 29334481)
25. Szary J, Szala S. Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth. Int J Cancer 2001;91:835-9. (Pubitemid 32178653)
26. Joki T, Machluf M, Atala A, et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat Biotechnol 2001;19:35-9. (Pubitemid 32051953)
27. Chen CT, Lin J, Li Q, et al. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin. Hum Gene Ther 2000;11:1983-96.
28. Feldman AL, Restifo NP, Alexander HR, et al. Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice. Cancer Res 2000;60:-1503-6.
29. Sauter BV, Martinet O, Zhang WJ, Mandeli J, Woo SL. Adenovirus mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. Proc Natl Acad Sci USA 2000;97:4802-7. (Pubitemid 30238638)
30. Kyoko H, Lee J, Yoshie M, Naoki T, Hideo N, Toshimitsu H. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. J Gen Med 2006;8:1056-67. (Pubitemid 44283002)